Abstract
Coagulation factor XI is activated in vitro by factor XIIa in the presence of high molecular weight kininogen (HMWX) and a negatively charged surface. Factor XII deficiency is not associated with bleeding, which suggests that another mechanism for factor XI activation exists in vivo. A revised model of coagulation is proposed in which factor XI is activated by thrombin. In the absence of cofactors, thrombin is more effective (kcat/Km = 1.6 × 105) than factor XIIa (1.7 × 104) in activating factor XI. Dextran sulfate enhances activation of factor XI by thrombin 2000-fold; part of this effect is due to autoactivation of factor XI by activated factor XI.
| Original language | English |
|---|---|
| Pages (from-to) | 909-912 |
| Number of pages | 4 |
| Journal | Science |
| Volume | 253 |
| Issue number | 5022 |
| DOIs | |
| State | Published - 1991 |
Fingerprint
Dive into the research topics of 'Factor XI activation in a revised model of blood coagulation'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver